12 Feb 2026
New Medicines and Vaccines Under Review by PBAC
The Pharmaceutical Benefits Advisory Committee (PBAC) has published its latest meeting agenda, outlining which medicines and vaccines are being considered for listing or changes under the Pharmaceutical Benefits Scheme (PBS) and the National Immunisation Program (NIP).
01 Feb 2026
PBS Updates – Feb 2026
The PBS website has the newest information on medicines, highlighting new, updated, and removed items.
09 Jan 2026
PBAC Invites Consumer Comments for March 2026 Meeting
Closing date for comments: Wednesday, 21 January 2026
01 Oct 2025
1 October 2025 Designated Brand List – Minimum Stockholding Requirements
1 October 2025 Designated Brand List – Minimum Stockholding Requirements
23 Sep 2025
Outcome Statement for August 2025 Pulmonary Arterial Hypertension Stakeholder Meeting Released
Outcome Statement for August 2025 Pulmonary Arterial Hypertension Stakeholder Meeting Released
18 Sep 2025
Department requests earlier Notices of Intent for PBAC submissions
The Department of Health recently held a webinar on Thursday 11 September 2025 to explain its request for earlier submission of Notices of Intent (NOIs) and additional supporting information. The aim is to help with meeting planning and to publish more informative agendas. Thank you to all sponsors who submitted NOIs by 17 September 2025.
11 Sep 2025
Outcome Statement – July 2025 Stakeholder Meeting: Multiple Myeloma
Outcome Statement – July 2025 Stakeholder Meeting: Multiple Myelom
29 Aug 2025
Updated Public Summary Documents from the May 2025 PBAC Meeting
Updated Public Summary Documents from the May 2025 PBAC Meeting
08 Aug 2025
Advice regarding Xolair (omalizumab) Claiming
Advice-regarding-xolair-omalizumab-claiming
